BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25762097)

  • 21. Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation.
    Kratz AS; Richter KT; Schlosser YT; Schmitt M; Shumilov A; Delecluse HJ; Hoffmann I
    Cell Cycle; 2016 Dec; 15(24):3419-3431. PubMed ID: 27754753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin.
    Yan T; Deng S; Metzger A; Gödtel-Armbrust U; Porter AC; Wojnowski L
    Mol Cancer Ther; 2009 May; 8(5):1075-85. PubMed ID: 19417146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meiotic events at the centromeric heterochromatin: histone H3 phosphorylation, topoisomerase II alpha localization and chromosome condensation.
    Cobb J; Miyaike M; Kikuchi A; Handel MA
    Chromosoma; 1999 Dec; 108(7):412-25. PubMed ID: 10654080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
    Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
    Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DDK dependent regulation of TOP2A at centromeres revealed by a chemical genetics approach.
    Wu KZ; Wang GN; Fitzgerald J; Quachthithu H; Rainey MD; Cattaneo A; Bachi A; Santocanale C
    Nucleic Acids Res; 2016 Oct; 44(18):8786-8798. PubMed ID: 27407105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction with TopBP1 Is Required for Human Papillomavirus 16 E2 Plasmid Segregation/Retention Function during Mitosis.
    Prabhakar AT; James CD; Das D; Fontan CT; Otoa R; Wang X; Bristol ML; Morgan IM
    J Virol; 2022 Aug; 96(16):e0083022. PubMed ID: 35880889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of anaphase DNA bridge recognition and disjunction.
    Sarlós K; Biebricher AS; Bizard AH; Bakx JAM; Ferreté-Bonastre AG; Modesti M; Paramasivam M; Yao Q; Peterman EJG; Wuite GJL; Hickson ID
    Nat Struct Mol Biol; 2018 Sep; 25(9):868-876. PubMed ID: 30177760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TopoIIα prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres.
    d'Alcontres MS; Palacios JA; Mejias D; Blasco MA
    Cell Cycle; 2014; 13(9):1463-81. PubMed ID: 24626180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sister chromatids separate during anaphase in a three-stage program as directed by interaxis bridges.
    Chu L; Zhang Z; Mukhina M; Zickler D; Kleckner N
    Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2123363119. PubMed ID: 35235450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights from the crystal structure of the sixth BRCT domain of topoisomerase IIbeta binding protein 1.
    Leung CC; Kellogg E; Kuhnert A; Hänel F; Baker D; Glover JN
    Protein Sci; 2010 Jan; 19(1):162-7. PubMed ID: 19937654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
    Fountzilas G; Dafni U; Bobos M; Kotoula V; Batistatou A; Xanthakis I; Papadimitriou C; Kostopoulos I; Koletsa T; Tsolaki E; Televantou D; Timotheadou E; Koutras A; Klouvas G; Samantas E; Pisanidis N; Karanikiotis C; Sfakianaki I; Pavlidis N; Gogas H; Linardou H; Kalogeras KT; Pectasides D; Dimopoulos MA
    BMC Cancer; 2013 Mar; 13():163. PubMed ID: 23537287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SUMOylation of DNA topoisomerase IIα regulates histone H3 kinase Haspin and H3 phosphorylation in mitosis.
    Yoshida MM; Ting L; Gygi SP; Azuma Y
    J Cell Biol; 2016 Jun; 213(6):665-78. PubMed ID: 27325792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.
    Liang Z; Zeng X; Gao J; Wu S; Wang P; Shi X; Zhang J; Liu T
    BMC Cancer; 2008 Dec; 8():363. PubMed ID: 19061514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Condensin-dependent localisation of topoisomerase II to an axial chromosomal structure is required for sister chromatid resolution during mitosis.
    Coelho PA; Queiroz-Machado J; Sunkel CE
    J Cell Sci; 2003 Dec; 116(Pt 23):4763-76. PubMed ID: 14600262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TopBP1 localises to centrosomes in mitosis and to chromosome cores in meiosis.
    Reini K; Uitto L; Perera D; Moens PB; Freire R; Syväoja JE
    Chromosoma; 2004 May; 112(7):323-30. PubMed ID: 15138768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chromatin remodeling complex regulates topoisomerase IIα function.
    Cancer Discov; 2013 Jul; 3(7):OF33. PubMed ID: 23847378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of hCAP-D2, a non-SMC subunit of condensin I, to chromosome and chromosomal protein dynamics during mitosis.
    Watrin E; Legagneux V
    Mol Cell Biol; 2005 Jan; 25(2):740-50. PubMed ID: 15632074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.
    Sapetto-Rebow B; McLoughlin SC; O'Shea LC; O'Leary O; Willer JR; Alvarez Y; Collery R; O'Sullivan J; Van Eeden F; Hensey C; Kennedy BN
    BMC Dev Biol; 2011 Nov; 11():71. PubMed ID: 22111588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.
    Trinh BQ; Ko SY; Barengo N; Lin SY; Naora H
    Cancer Res; 2013 Jan; 73(2):1000-10. PubMed ID: 23222298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer.
    de Resende MF; Vieira S; Chinen LT; Chiappelli F; da Fonseca FP; Guimarães GC; Soares FA; Neves I; Pagotty S; Pellionisz PA; Barkhordarian A; Brant X; Rocha RM
    J Transl Med; 2013 Feb; 11():36. PubMed ID: 23398928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.